<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02283645</url>
  </required_header>
  <id_info>
    <org_study_id>REH-57080</org_study_id>
    <nct_id>NCT02283645</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement</brief_title>
  <official_title>Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement : A Randomized, Double-blind, Placebo-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mae Fah Luang University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mae Fah Luang University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for
      chest hair enhancement.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of global photographic assessment after 20 weeks from baseline</measure>
    <time_frame>baseline and 20 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change in number of hairs after 20 weeks from baseline</measure>
    <time_frame>baseline and 20 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>The change of hair diameter after 20 weeks from baseline</measure>
    <time_frame>baseline and 20 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of participants with adverse events</measure>
    <time_frame>baseline and 20 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient satisfaction by self-assessment questionnaires</measure>
    <time_frame>baseline and 20 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Chest Hair Enhancement</condition>
  <arm_group>
    <arm_group_label>Minoxidil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3% Minoxidil lotion is applied twice daily to the chest.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo lotion is applied twice daily to the chest.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>3 % minoxidil lotion</intervention_name>
    <arm_group_label>Minoxidil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy male

        Exclusion Criteria:

          -  serious underlying diseases

          -  history of chest/ hair treatment before 6 months

          -  history of surgery or trauma on chest area.

          -  history of minoxidil allergy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chuchai Tanglertsampan, MD</last_name>
    <email>drchuchait@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sittichai Ingprasert, MD</last_name>
    <email>sittichai113@hotmail.com</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Lee S, Tanglertsampan C, Tanchotikul M, Worapunpong N. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study. J Dermatol. 2014 Feb;41(2):149-52. doi: 10.1111/1346-8138.12275. Epub 2013 Nov 8.</citation>
    <PMID>24471459</PMID>
  </results_reference>
  <results_reference>
    <citation>Suwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012 Oct;39(10):865-6. doi: 10.1111/j.1346-8138.2012.01579.x. Epub 2012 May 17.</citation>
    <PMID>22594928</PMID>
  </results_reference>
  <results_reference>
    <citation>Tanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai. 2012 Oct;95(10):1312-6.</citation>
    <PMID>23193746</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2014</study_first_submitted>
  <study_first_submitted_qc>November 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2014</study_first_posted>
  <last_update_submitted>November 29, 2014</last_update_submitted>
  <last_update_submitted_qc>November 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mae Fah Luang University Hospital</investigator_affiliation>
    <investigator_full_name>Chuchai TANGLERTSAMPAN, MD</investigator_full_name>
    <investigator_title>Assitant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Minoxidil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

